3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
4
Phase 4
4
Phase EARLY_PHASE1
2
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
2
Smoking Cessation
1
Neoplasms, Second Primary
1
Hand-Foot Syndrome
1
Cigarette Smoking
1
Chemotherapy-Related Cognitive Impairment
1
Behavior, Addictive
1
Interventions
Aspirin
2
sulforaphane
1
polyphenon E
1
cytisine
1
Varenicline
1
Tomography, X-Ray Computed
1
Tomography
1
Tobacco Use Cessation Devices
1
Tea
1
Spirometry
1
Secondary Prevention
1
Positron-Emission Tomography
1
Positron Emission Tomography Computed Tomography
1
Nicotine Chewing Gum
1
Hematologic Tests
1
Fluorodeoxyglucose F18
1
Exercise
1
Diet Therapy
1
Diagnostic Imaging
1
Bupropion
1
4-(3-fluoropropyl)glutamic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Smoking Cessation
×
Tobacco Use Cessation Devices
×
Clear all
NCT04634071
2026-02-02
TTOP
University of Kentucky
Phase 2
Completed
126 enrolled